ZYVERSA THERAPEUTICS INC (ZVSA)
US98987D3008 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 122.92K | 3.14M | 5.90M | 329.00K | 175.00K | |||
| Other Current Assets | 267.49K | 215.00K | 460.00K | 483.00K | 164.00K | |||
| Total Current Assets | 390.42K | 3.35M | 6.36M | 812.00K | 339.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 15.00K | 116.00K | 28.00K | 38.00K | |||
| Goodwill | N/A | 0.00 | 11.89M | 0.00 | N/A | |||
| Intangibles | 18.65M | 18.65M | 100.09M | 0.00 | N/A | |||
| Other Non-Current Assets | 385.61K | 98.00K | 47.00K | 287.00K | 308.00K | |||
| Total Non-Current Assets | 19.03M | 18.76M | 112.14M | 314.00K | 347.00K | |||
| TOTAL ASSETS | 19.42M | 22.11M | 118.51M | 1.13M | 686.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 9.15M | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 2.13M | |||
| Accrued Expenses | 2.26M | 1.76M | 2.06M | 1.91M | 2.33M | |||
| Accounts Payable | 9.28M | 8.43M | 6.03M | 2.00M | 2.31M | |||
| Other Current Liabilities | N/A | N/A | 107.00K | 561.00K | 789.00K | |||
| Total Current Liabilities | 11.54M | 10.20M | 8.19M | 13.63M | 7.56M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.69M | |||
| Deferred Taxes/Income | 854.62K | 845.00K | 10.32M | 0.00 | N/A | |||
| Total Non-Current Liabilities | 854.62K | 845.00K | 10.32M | 0.00 | 1.69M | |||
| TOTAL LIABILITIES | 12.40M | 11.04M | 18.51M | 13.63M | 9.24M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -111.21M | -103.22M | -4.92M | -52.90M | -44.81M | |||
| Additional Paid In Capital | 118.25M | 114.30M | 104.58M | 40.06M | 35.92M | |||
| Common Shares | 110.00 | 0.00 | 332.00K | 332.00K | 332.00K | |||
| Treasury Stock | -7.17K | -7.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 1.07M | 405.00K | 26.00K | 26.00K | 26.00K | |||
| Tangible Book Value per Share | -10.82 | -18.70 | -461.04 | -480.77 | -329.15 | |||
| Total Shareholders' Equity | 7.03M | 11.07M | 99.99M | -12.50M | -8.56M | |||
| TOTAL LIABILITIES AND EQUITY | 19.42M | 22.11M | 118.51M | 1.13M | 686.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -0.20 | |||
| Current Ratio | 0.03 | 0.33 | 0.78 | 0.06 | 0.04 | |||
| Return On Assets (ROA) | -109.81% | -480.45% | -20.37% | -717.96% | -1848.86% | |||
| Return On Equity (ROE) | -303.53% | -959.33% | -24.14% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21